Endothelial function as a marker of pre-clinical atherosclerosis: Assessment techniques and clinical implications;Funzione endoteliale quale marker di aterosclerosi subclinica: Metodiche di valutazione ed applicazioni cliniche

Monaldi Archives for Chest Disease - Cardiac Series

Volumn 80, Issue 3, 2014, Pages 106-110

  Ruggiero, Donatella ^a   Paolillo, Stefania ^a   Ratta, Giuseppe Della ^a   Mariniello, Antonio ^a   Formisano, Tiziana ^a   Pellegrino, Angela Maria ^a   Filardi, Pasquale Perrone ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Coronary atherosclerosis; Endothelial dysfunction; Endothelium; Nitric oxide

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; EX VIVO STUDY; FLOW MEDIATED DILATATION; HUMAN; IN VIVO STUDY; LASER DOPPLER FLOWMETRY; NON INVASIVE MEASUREMENT; PLETHYSMOGRAPHY; PULSE AMPLITUDE TONOMETRY; PULSE WAVE; REVIEW; TONOMETRY; VASODILATATION; VEIN OCCLUSION;

EID: 84982987623     PISSN: 11220643     EISSN: 24651028     Source Type: Journal    
DOI: 10.4081/monaldi.2013.71     Document Type: Review

References (23)

1. Schiffrin EL. A critical review of the role of endothelial factors in the pathogenesis of hypertension. J Cardiovasc Pharmacol 2001; 38 (suppl 2) : S3-S6.
2. Inoue T, Saniabadi AR, Matsunaga R, Hoshi K, Yaguchi I, Morooka S. Impaired endothelium-dipendent acetylcholine-induced coronary artery relazation in patients with high serum remnant lipoprotein particles. Atherosclerosis 1998; 139: 363-7.
3. Verma S, Anderson TJ. Fundamentals of Endothelial Function for the Clinical Cardiologist. Circulation 2002; 105: 546-9.
4. Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002 Aug 6; 106 (6): 653-8.
5. Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation 2003; 108: 2054-2059.
6. Pitkänen OP, Nuutila P, Raitakari OT, et al. Coronary flow reserve in young men with familial combined hyperlipidemia. Circulation 1999 Apr 6; 99 (13): 1678-84.
7. Yokoyama I, Momomura S, Ohtake T, et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1997 Nov 15; 30 (6): 1472-7.
8. Campisi R, Czernin J, Schöder H, et al. Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. Circulation 1998 Jul 14; 98 (2): 119-25.
9. Hirsch A, Nijveldt R, Haeck JD, et al. Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction. J Am Coll Cardiol 2008 Jun 10; 51 (23): 2230-8.
10. Pedersen SF, Thrysøe SA, Paaske WP et al.CMR assessment of endothelial damage and angiogenesis in porcine coronary arteries using gadofosveset. J Cardiovasc Magn Reson 2011 Jan 26; 13: 10.
11. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2003 Jul 29; 108 (4): 500.
12. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significante of endothelial dysfunction in hypertensive patients. Circulation 2001; 104; 191-6.
13. Hayward CS, Kraidly M, Webb CM, Collins P. Assessment of endothelial function using peripheral waveform analysis: a clinical application. J Am Coll Cardiol 2002 Aug 7; 40 (3): 521-8.
14. Neunteufl T, Heher S, Katzenschlager R, et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000; 86: 207-10.
15. Gocke N, Keaney J, Hunter LM, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003; 41: 1769-75.
16. Perrone-Filardi, Cuocolo A, Brevetti G, et al. Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease. Am J Cardiol 2005; 96: 1337-41.
17. Kuvin JT, Patel AR, Sliney KA, et al. Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol 2001 38: 1843-9.
18. Kastelein JJ, Duivenvoorden R, Deanfield J, et al. Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-mediated vasodilatation. Curr Med Res Opin 2011 Jan; 27 (1): 141-150.
19. Bonetti PO, Pumper GM, Higano ST, Holmes Jr DR, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004; 44 (11): 2137-41.
20. Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008 May 13; 117 (19): 2467-74.
21. Gargiulo P, Marciano C, Savarese G, et al. endothelial dysfunction in type 2 diabetic patients with normal coronary arteries. A digital resctive hyperemia study. Int J Cardiol 2011 August 16. (Epub ahead of print).
22. Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010; 31 (9): 1142-8.
23. Faglia E, Favales F, Calia P, et al. Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care 2002; 25: 2032-6.